9684
R. Judele et al. / Tetrahedron 62 (2006) 9681–9687
(
8
1008.6): C, 66.64; H, 8.39; N, 2.78. Found: C 66.73; H,
.38; N, 2.75.
3.1.2.6. 4,5-Dinitro-2-{[3,4,5-tris(decyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(decyloxy)benzoate (1f). H NMR
1
(
300 MHz, CDCl ): d¼0.88 (t, J¼6.4 Hz, 18H; 6CH ),
3
3
3.1.2.3. 4,5-Dinitro-2-{[3,4,5-tris(heptyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(heptyloxy)benzoate (1c). Mp 63 C.
1.27–1.56 (m, 84H; 6(CH ) CH ), 1.68–1.79 (m, 12H;
2 7 3
ꢁ
6OCH CH ), 3.82 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01 (t,
2
2
2
1
H NMR (300 MHz, CDCl ): d¼0.89 (t, J¼6.6 Hz, 18H;
J¼6.5 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s, 2H;
3 3
3
2
1
3
6
1
CH ), 1.30–1.57 (m, 48H; 6(CH ) CH ), 1.70–1.80 (m,
3
Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.0 (6CH ),
2 4
3
2H; 6OCH CH ), 3.82 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01 (t,
22.6, 26.0, 26.1, 29.3, 29.4, 29.5, 29.6, 29.66, 29.74, 30.3,
31.9 (6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ), 108.6
2
2
2
J¼6.5 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s, 2H;
2
3
2 8
2
2
1
3
Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.0 (6CH ),
(4CH), 120.7 (2CH), 121.0, 140.0, 144.0, 145.9, 153.0,
162.5 (2CO) ppm. FTIR (ATR): 2917 (vs), 2849 (vs), 1743
(vs), 1590 (m), 1535 (vs), 1430 (vs), 1334 (vs), 1277 (vs),
1192 (s), 1167 (vs), 1117 (vs), 784 (s), 743 (m), 633
3
3
2
(
2.6, 22.7, 25.9, 26.0, 29.0, 29.1, 29.2, 30.3, 31.8, 31.9
6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ), 108.5 (4CH),
3
2 5
2
2
1
(
20.7 (2CH), 121.0, 140.0, 144.0, 145.8, 153.0, 162.5
2CO) ppm. FTIR (ATR): 2924 (vs), 2854 (vs), 1746 (vs),
ꢀ
1
(m) cm . UV–vis (CH Cl ): l
max
(log 3)¼276 (3.42), 229
2
2
1
1
735 (vs), 1589 (m), 1552 (vs), 1539 (vs), 1466 (m),
429 (vs), 1332 (vs), 1276 (vs), 1186 (vs), 1159 (vs), 1113
(0.70), 205 (0.53). MS (ESI), m/z (%): 1367.9 (100)
[M +Na], 1362.9 (20) [M +NH ], 1345.9 (10) [M +H].
+
+
+
4
ꢀ
1
(
(
(
[
(
vs), 930 (m), 744 (m) cm . UV–vis (CH Cl ): l
2
Anal. calcd for C H N O (1345.0): C, 71.39; H, 9.89;
80 132 2 14
N, 2.08. Found: C, 71.47; H, 9.95; N, 2.05.
2
max
log 3)¼277 (3.42), 229 (0.74). MS (ESI), m/z (%): 1115.7
+
+
100) [M +Na], 1110.7 (35) [M +NH ], 1093.7 (12)
4
+
+
M +H], 1092.7 (10) [M ]. Anal. calcd for C H N O
2 96 2 14
1092.7): C, 68.10; H, 8.85; N, 2.56. Found: C, 68.01; H,
.70; N, 2.48.
3.1.2.7. 4,5-Dinitro-2-{[3,4,5-tris(undecyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(undecyloxy)benzoate (1g). H NMR
6
1
8
(300 MHz, CDCl ): d¼0.88 (t, J¼6.2 Hz, 18H; 6CH ),
3
3
1.26–1.58 (m, 96H; 6(CH ) CH ), 1.68–1.79 (m, 12H;
2 8 3
3.1.2.4. 4,5-Dinitro-2-{[3,4,5-tris(octyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(octyloxy)benzoate (1d). H NMR
6OCH CH ), 3.81 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01 (t,
2
2
2
1
J¼6.5 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s, 2H;
3 3
2
1
3
(
1
300 MHz, CDCl ): d¼0.88 (t, J¼6.3 Hz, 18H; 6CH ),
Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.1 (6CH ),
3
3
.28–1.56 (m, 60H; 6(CH ) CH ), 1.68–1.79 (m, 12H;
3
22.6, 26.0, 26.1, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 30.3,
31.9 (6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ), 108.6
2
5
6
OCH CH ), 3.82 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01 (t,
2
2
2
3
2 9
2
2
J¼6.5 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s,
(4CH), 120.7 (2CH), 121.1, 140.0, 144.0, 145.9, 153.0,
162.5 (2CO) ppm. FTIR (ATR): 2917 (vs), 2849 (vs), 1743
(vs), 1590 (m), 1535 (vs), 1430 (vs), 1334 (vs), 1277 (vs),
1192 (vs), 1167 (vs), 1118 (vs), 930 (m), 742 (m), 721
2
13
2
H; Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.0
3
(
(
(
6CH ), 22.6, 26.1, 29.2, 29.3, 29.5, 30.3, 31.8, 31.9
3
6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ), 108.5
3
4CH), 120.7 (2CH), 121.0, 140.0, 144.0, 145.8, 153.0,
62.5 (2CO) ppm. FTIR (ATR): 2918 (vs), 2851 (s), 1740
vs), 1735 (vs), 1591 (m), 1534 (vs), 1430 (m), 1333 (vs),
276 (vs), 1193 (vs), 1166 (vs), 1115 (vs), 743 (m), 633
2 6
2
2
ꢀ
1
(m) cm . UV–vis (CH Cl ): l
max
(log 3)¼285 (3.17), 229
2
2
1
(
1
(0.66), 207 (0.51). MS (MALDI-TOF), m/z (%): 1431.0
+
+
(92) [M +H], 1430.0 (100) [M ]. Anal. calcd for
C H N O (1429.1): C, 72.23; H, 10.15; N, 1.96. Found:
C, 71.59; H, 9.96; N, 1.89.
8
6 144 2 14
ꢀ1
(
m) cm . UV–vis (CH Cl ): l
max
(log 3)¼282 (3.37),
2
2
2
(
29 (0.67), 208 (0.51). MS (ESI), m/z (%): 1199.8
100) [M +Na], 1194.8 (35) [M +NH ], 1177.8 (37)
+
+
3.1.2.8. 4,5-Dinitro-2-{[3,4,5-tris(dodecyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(dodecyloxy)benzoate (1h). H NMR
4
+
1
[M +H]. HRMS (EI) calcd 1176.7801 (for C H N O ),
found 1176.7838 [M ]. Anal. calcd for C H N O
6
8 108 2 14
+
(300 MHz, CDCl ): d¼0.88 (t, J¼6.2 Hz, 18H; 6CH ),
6
8
108
2
14
3
3
(
9
1176.8): C, 69.36; H, 9.24; N, 2.38. Found: C, 69.19; H,
.11; N, 2.40.
1.26–1.56 (m, 108H; 6(CH ) CH ), 1.68–1.76 (m, 12H;
2 9 3
6OCH CH ), 3.81 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01 (t,
2
2
2
J¼6.4 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s, 2H;
2
1
3
3.1.2.5. 4,5-Dinitro-2-{[3,4,5-tris(nonyloxy)benzoyl]-
oxy}phenyl 3,4,5-tris(nonyloxy)benzoate (1e). Mp 62 C.
Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.1 (6CH ),
3
3
ꢁ
22.6, 26.0, 26.1, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 30.3,
31.9 (6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ), 108.5
1
H NMR (300 MHz, CDCl ): d¼0.88 (t, J¼6.3 Hz, 18H;
3
3
2 10
2
2
6
1
(
2
(
CH ), 1.27–1.56 (m, 72H; 6(CH ) CH ), 1.68–1.79 (m,
3
(4CH), 120.7 (2CH), 121.0, 140.0, 144.0, 145.9, 153.0,
162.5 (2CO) ppm. FTIR (ATR): 2917 (vs), 2849 (vs), 1742
(vs), 1591 (m), 1534 (vs), 1430 (vs), 1334 (s), 1277 (vs),
1192 (vs), 1167 (s), 1116 (vs), 933 (m), 825 (m), 742 (m),
2 6
3
2H; 6OCH CH ), 3.82 (t, J¼6.3 Hz, 8H; 4OCH ), 4.01
2
2
2
t, J¼6.5 Hz, 4H; 2OCH ), 7.22 (s, 4H; Ar-H), 8.08 (s,
2
13
H; Ar-H) ppm. C NMR (75 MHz, CDCl ): d¼14.0
3
3
ꢀ
1
6CH ), 22.6, 29.2, 29.32, 29.37, 29.4, 29.61, 29.68, 30.3,
721 (m), 606 (m) cm
.
UV–vis (CH Cl ): lmax
2 2
3
1
1
1.91, 31.94 (6CH (CH ) ), 69.1 (4OCH ), 73.6 (2OCH ),
3
08.6 (4CH), 120.7 (2CH), 121.1, 140.0, 144.0, 145.9,
53.0, 162.5 (2CO) ppm. FTIR (ATR): 2918 (vs), 2849
(log 3)¼229 (0.74), 216 (0.64), 208 (0.59), 202 (0.54). MS
2 7
2
2
+
(MALDI-TOF), m/z (%): 1515.1 (100) [M +2H], 1514.1
+
+
(100) [M +H], 1513.0 (10) [M ]. Anal. calcd for
C H N O (1513.2): C, 72.97; H, 10.38; N, 1.85. Found:
C, 72.95; H, 10.14; N, 1.87.
(
1
vs), 1743 (vs), 1735 (vs), 1590 (m), 1535 (vs), 1430 (vs),
332 (vs), 1277 (vs), 1193 (vs), 1166 (vs), 1115 (vs), 742
9
2 156 2 14
ꢀ
1
(
(
m), 722 (m) cm . UV–vis (CH Cl ): l
max
1.16), 230 (0.45), 221 (0.42), 208 (0.35). MS (ESI),
(log 3)¼286
2
2
3.1.3. General procedure for the preparation of 2-{[3,4,5-
tris(alkyloxy)benzoyl]oxy}phenyl 3,4,5-tris(alkyloxy)-
benzoates 6a–h. DCC (3.1 equiv) was added to a cooled
solution of the appropriate 5 (2.2 equiv) in CH Cl (7–
+
+
m/z (%): 1284.0 (100) [M +Na], 1278.9 (18) [M +NH ],
4
+
+
1262.0 (35) [M +2H], 1260.8 (8) [M ]. Anal. calcd for
C H N O (1260.9): C, 70.44; H, 9.59; N, 2.22. Found:
C, 70.22; H, 9.48; N, 2.10.
7
4
120
2
14
2
2
ꢁ
10 mL) at 0 C. After stirring for 10 min, DMAP and 2b